Compare Huntington Bancshares Incorporated (HBAN) vs HCA Health Inc (HCA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Huntington Bancshares Incorporated vs HCA Health Inc — how do they compare? Huntington Bancshares Incorporated trades at $15.29 (market cap $31.04B), while HCA Health Inc trades at $447.89 (market cap $96.35B). The key difference: HCA Health Inc is far larger — about 3.1× Huntington Bancshares Incorporated's market cap, and Huntington Bancshares Incorporated pays the higher dividend (4.04%). Which is the better fit depends on your goals — on Pluang, investors hold Huntington Bancshares Incorporated for 52 Days and HCA Health Inc for 76 Days on average.
| HBAN | HCA | |
|---|---|---|
Market Cap | $31.04B | $96.35B |
Volume | 23,864,172 | 1,079,453 |
Sector | Financials | Health |
52-Week High | $19.27 | $545.13 |
52-Week Low | $15.02 | $361.32 |
Typical Hold Time | 52 Days | 76 Days |
Enterprise Value | $49.57B | $146.88B |
Dividend Yield | 4.04% | 0.7% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Huntington Bancshares (HBAN) trades at $15.17, down 1.04% on the day, with a bearish technical signal. The company reported mixed quarterly earnings, missing in Q4 2025 and Q2 2026 but beating in Q1 2026, while revenue grew to $8.13B in 2025. Analyst consensus is split evenly between Buy and Hold, with a $19.60 price target suggesting upside. Recent news highlights margin pressures from higher interest rates and a revised 2027 outlook.
HBAN offers value with a P/E of 11.82 and pays a dividend, but faces headwinds from net interest margin compression and loan growth challenges. The stock's near-term performance hinges on Q3 2026 earnings and management's ability to navigate rate environment pressures.
HCA Healthcare (HCA) trades at $439.17, up 1.61% today, with a bullish technical signal and strong fundamental performance. Revenue grew to $75.6 billion in 2025, with net income reaching $6.78 billion, and the company has beaten EPS estimates for three consecutive quarters. Recent news includes an upcoming Q3 2026 earnings call and the completion of the College of Health Care Professions acquisition, highlighting operational expansion.
The outlook remains positive with a consensus price target of $461.12, though risks include ongoing legal investigations and high debt levels. Earnings growth and cost controls support upside potential, but investors should monitor regulatory developments and payer-mix pressures that could impact margins.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Huntington Bancshares Incorporated
Huntington Bancshares is a regional bank holding company headquartered in Columbus, Ohio. The bank has a network of branches and ATMs across eight Midwestern states. Founded in 1866, Huntington National Bank and its affiliates provide consumer, small-business, commercial, treasury management, wealth management, brokerage, trust, and insurance services. Huntington also provides auto dealer, equipment finance, national settlement, and capital market services that extend beyond its core states.
Read more on HBAN →About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →
